Skip to main content
. 2018 Apr 13;9(28):19994–20007. doi: 10.18632/oncotarget.25017

Figure 2. MAbs KU42.33C and KU43.13A are directed against distinct epitopes on BxPC-3 human pancreatic cancer cells.

Figure 2

BxPC-3 cells were grown in 96-well plates to near confluency. MAb KU42.33C was added in doubling dilutions at highest concentration of 25 μg/ml for 1 hour on ice. After washing unbound antibodies, increasing concentrations of mAb KU42.33C or mAb KU43.13A were added and the total level of bound antibodies were determined as described in Materials and Method section. Data is presented as mean absorbance at 450 nm ± SD.